Early conversion to cabazitaxel for castration-resistant prostate cancer
Not Applicable
Recruiting
- Conditions
- castration-resistant prostate cancer
- Registration Number
- JPRN-UMIN000035375
- Lead Sponsor
- Sapporo Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. No previous cabazitaxel treatment 2. Active concomitant malignancy in 3 years except for prostate cancer 3. Difficult to control severe complications except for malignancy 4. Seizure to be treated with anticonvulsant 5. Severe liver dysfunction 6. Allergy for cabazitaxel, docetaxel and predonisolone 7. Neither ability nor will to cooperate the study 8. Unfit for enrollment by physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method